Aims/hypothesis Fibroblast growth factor 21 (FGF21) is an endocrine hormone that exhibits anti-diabetic and anti-obesity activity. FGF21 expression is increased in patients with and mouse models of obesity or nonalcoholic fatty liver disease (NAFLD). However, the functional role and molecular mechanism of FGF21 induction in obesity or NAFLD are not clear. As endoplasmic reticulum (ER) stress is triggered in obesity and NAFLD, we investigated whether ER stress affects FGF21 expression or whether FGF21 induction acts as a mechanism of the unfolded protein response (UPR) adaptation to ER stress induced by chemical stressors or obesity.
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Introduction
Fibroblast growth factor 21 (FGF21) is an endocrine hormone produced predominantly in the liver but also in white adipose tissue (WAT), brown adipose tissue (BAT), pancreas and skeletal muscle [1, 2] . In starvation, FGF21 promotes lipolysis, beta oxidation or ketogenesis [3] , indicating that FGF21 is a critical regulator of lipid homeostasis in adaptation to starvation. FGF21 can improve deteriorated metabolic variables in obese diabetic humans and in animal models of obesity and diabetes [4] [5] [6] [7] . In addition, FGF21 plays a protective role in toxin-induced tissue injury [8, 9] . Protein folding occurs in the endoplasmic reticulum (ER). Perturbations of ER homeostasis cause accumulation of misfolded proteins in the ER lumen, triggering the unfolded protein response (UPR), an adaptive programme to resolve misfolded protein accumulation in the ER [10] . The UPR is regulated through three ER transmembrane sensors: inositol-requiring 1α (IRE1α), activating transcription factor 6α (ATF6α) and PKR-like ER kinase (PERK) [10] . X-box binding protein 1 (XBP1) and eukaryotic translation factor 2α (eIF2α)-activating transcription factor 4 (ATF4) participate in various adaptive responses to ER stress downstream of IRE1α and PERK, respectively. Unresolved ER stress leads to the development and progression of various diseases such as obesity and diabetes [11, 12] .
Recent studies reported that FGF21 is increased in the liver in mouse models of and humans with obesity or nonalcoholic fatty liver disease (NAFLD) [13] [14] [15] . However, little is known about the functional role and molecular mechanism of FGF21 induction in these conditions. As ER stress is elevated in obesity [16] , we investigated the relationship between ER stress and FGF21 induction. We found that FGF21 is induced by ER stress in a PERK-eIF2α-ATF4-dependent manner. In addition, we observed that FGF21 deletion accelerates ER stress-induced hepatic injury or lipid accumulation, and exacerbates obesity-induced ER stress and metabolic deterioration. These results suggest that FGF21 may play a role in the adaptive response to ER stress induced by a pharmacological ER stressor or obesity.
Methods

Animal experiments Fgf21
+/+ and Fgf21 −/− mice have been described elsewhere [17] . Fgf21 +/− mice were crossed with ob/w mice (Jackson Laboratory, Bar Harbor, ME, USA) to generate Fgf21 +/+ ob/ob and Fgf21 −/− ob/ob mice. Mice with a liver-specific defect in eIF2α phosphorylation (Eif2α A/A /fTg/ Alfp-Cre) were generated by breeding Eif2α
A/A /fTg mice [18] with Eif2α S/A /Alfp-Cre mice. Liver-specific inducible Fgf21-transgenic (Apoe-rtTA*M2/TetO-Fgf21) mice were generated using a tetracycline-inducible system. Fgf21-null and inducible Fgf21-transgenic mice were maintained in a specific pathogen-free facility of Samsung Biomedical Research Institute. Eif2α mutant mice were maintained under a specific pathogen-free condition in the laboratory animal care facility of the University of Ulsan. All animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee of Samsung Biomedical Research Institute or University of Ulsan. See Electronic Supplementary Material (ESM) Methods for details.
GTT, insulin tolerance test and pyruvate tolerance test GTTs and pyruvate tolerance tests (PTTs) were performed in overnight-fasted mice with intraperitoneal injection of glucose (1 g/kg) and pyruvate (1 g/kg), respectively. An insulin tolerance test (ITT) was conducted in 6 h-fasted mice with an intraperitoneal injection of insulin (1 U/kg). Blood glucose levels were measured with an Accu-Check glucometer (Roche, Mannheim, Germany).
Ex vivo glucose-stimulated insulin secretion assay Pancreatic islets were isolated from female Fgf21 +/+ ob/ob and Fgf21 −/− ob/ob mice by collagenase digestion and Biocoll (Biochrom AG, Berlin, Germany) gradient centrifugation. See ESM Methods for details.
Plasmid constructs and reagents See ESM Methods for details.
Generation of adenovirus Adenoviruses expressing ATF4 or Flag-XBP1s were generated by homologous recombination between a linearised transfer vector (pAd-Track-ATF4 or pAd-Track-Flag-XBP1s) and an adenoviral backbone vector (pAd-Easy).
Cell culture FaO, AML12, HepG2 cells, primary mouse hepatocytes and mouse embryonic fibroblasts (MEFs) deficient in UPR genes were maintained at 37°C in a humid atmosphere of 5% CO 2 . See ESM Methods for details.
Luciferase assay See ESM Methods for details.
siRNA transfection See ESM Methods for details.
RNA analysis Real-time RT-PCR was conducted using SYBR Green Master Mix (Takara, Otsu, Shiga, Japan) and genespecific primers (ESM Table 1 
Results
ER stress induces FGF21 expression through PERK-eIF2α-ATF4 pathway in vitro To analyse the effect of ER stress on FGF21 expression in hepatocytes, mouse AML12 cells were treated with chemical ER stressors, tunicamycin and thapsigargin. We found that, remarkably, both tunicamycin and thapsigargin induced Fgf21 gene expression as well as upregulation of several UPR genes, including spliced Xbp1 (Xbp1s), Bip, Chop (also known as Ddit3) and Grp94 (Fig. 1a, b) . Additionally, FGF21 expression was increased in rat FaO, human HepG2 and primary mouse hepatocytes treated with ER stressors (Fig. 1b, c ). In parallel, FGF21 level was augmented in culture supernatant fractions of FaO cells treated with ER stressors (Fig. 1d ). These results demonstrate that ER stress induces FGF21 expression in various hepatocyte cell lines and primary hepatocytes. We next investigated the mechanisms by which ER stress increases FGF21 expression using MEFs deficient in ER stress sensors. Fgf21 induction by ER stressors was much weaker in Perk −/− MEFs compared with control MEFs (Fig. 1e) , while ER stressor-induced Fgf21 expression in Ire1α
, Atf6α −/− or Xbp1 −/− MEFs was comparable with that in control MEFs (ESM Fig. 1a-c) . Furthermore, adenovirusmediated overexpression of XBP1s had no effect on FGF21 expression (ESM Fig. 1d ). We next tested whether eIF2α and ATF4 downstream of PERK induce FGF21 expression. As expected, two ER stressors increased Fgf21 mRNA levels in Eif2α S/S (wild-type) and Atf4 +/+ MEFs, while Fgf21 induction was markedly attenuated in Eif2α
A/A MEFs (harbouring S51A mutation) and Atf4 −/− MEFs (Fig. 1f, g ). ATF4 knockdown consistently suppressed tunicamycin-induced Fgf21 expression ( Fig. 1h, i) , while ATF4 overexpression increased FGF21 mRNA expression and Fgf21 promoter activity ( Fig. 1j , k). However, XBP1s or ATF6α overexpression had no effect on luciferase activity (Fig. 1k) . Moreover, mutations of putative ATF4-response elements abolished the increase in Fgf21 promoter activity by ER stressors (Fig. 1l ), indicating that two ATF4-response elements are required for ER stressinduced FGF21 expression. Together, these findings suggest that the PERK-eIF2α-ATF4 pathway is critical for ER stressinduced FGF21 expression in vitro.
Hepatic eIF2α-ATF4 pathway is required for ER stressinduced FGF21 expression in vivo We investigated whether or not ER stress stimulates FGF21 expression in vivo. When we injected tunicamycin into male C57BL/6 mice, hepatic Fgf21 and UPR gene expression was induced accompanied by elevated serum FGF21 levels ( Fig. 2a -c, ESM Fig. 2 ). However, we did not observe a difference in Fgf21 expression in other tissues such as WAT or skeletal muscle ( Fig. 2b) , whereas Fgf21 expression in BAT appeared to be increased by tunicamycin administration (Fig. 2b ). This finding indicates that hepatic FGF21 induction is largely responsible for elevated circulating FGF21 level after tunicamycin administration.
To study the importance of the eIF2α-ATF4 axis in FGF21 induction by ER stress in vivo, we generated liver-specific Eif2α
A/A mice (Eif2α
/fTg/Alfp-Cre) with a homozygous Ser51Ala mutation in Eif2α alleles of the liver (Fig. 2d) .
Phosphorylation of eIF2α in the liver was not observed in Eif2α
A/A /fTg/Alfp-Cre mice (Fig. 2e) , confirming a defect in hepatic eIF2α phosphorylation in these mice. Importantly, we observed that hepatic expression of FGF21 or ATF4 and serum FGF21 level were markedly decreased in liverspecific Eif2α
A/A mice compared with control heterozygous Eif2α S/A /fTg mice under ER stress condition ( Fig. 2e-g ). These data indicate that the eIF2α-ATF4 pathway is critical for FGF21 induction in response to ER stress in vivo.
FGF21 suppresses ER stress response and alleviates ER stress-induced hepatic injury and lipid accumulation To study the physiological role of FGF21 induction by ER stress, we challenged Fgf21 −/− mice with tunicamycin and investigated changes in UPR signalling. As expected, there was no increase in serum FGF21 level in Fgf21 −/− mice after tunicamycin administration (ESM Fig. 3a) . Importantly, expression of UPR genes after tunicamycin treatment was significantly increased in the liver of Fgf21 −/− mice compared with control Fgf21 +/+ mice (Fig. 3a) . In parallel, levels of phosphorylated eIF2α, ATF4 and binding immunoglobulin protein (BIP) in the liver of Fgf21 −/− mice were higher compared with levels in control mice after tunicamycin treatment (Fig. 3b) . Furthermore, induction of the pro-apoptotic transcription factor CCAAT/enhancer binding protein homologous protein (CHOP) by tunicamycin was elevated in the liver of Fgf21 −/− mice compared with that of Fgf21 +/+ mice (Fig. 3b) , implying that FGF21 deletion may exacerbate liver injury caused by ER stress. In parallel, serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were increased in Fgf21 −/− mice under ER stress condition (Fig. 3c) . These results suggest that FGF21 plays a protective role in ER stress-induced liver injury. As ER stress can induce hepatic lipid accumulation [12] , we next studied the physiological role of FGF21 in ER stressmediated hepatosteatosis. Importantly, Fgf21
−/− mice exhibit- ( Fig. 3d, e) . When we analysed changes in the expression of genes involved in lipid metabolism, the expression of fatty acid and TG synthesis genes such as Scd1, Adrp (also known as Plin2) and Dgat2 appeared to be increased in the liver of Fgf21 −/− mice compared with that of Fgf21 +/+ mice under ER stress condition (Fig. 3a) . By contrast, we did not observe differences in the expression of genes such as Pparγ, Srebp1c (also known as Srebf1) and Acc1 (Fig. 3a) . The expression of Cd36, which is involved in lipid uptake, was also significantly increased in the liver of Fgf21 −/− mice compared with Fgf21 +/+ mice (Fig. 3a) . Additionally, we observed a tendency towards increased expression of the genes involved in beta oxidation, including Pparα and Mcad (also known as Acadm) in the liver of Fgf21 −/− mice compared with control mice after tunicamycin administration (ESM Fig. 3b) , which is likely to be an adaptive response to excessive TG accumulation caused by FGF21 deletion. These results indicate that enhanced hepatic lipid synthesis and uptake may contribute to increased hepatic TG accumulation in Fgf21 −/− mice under ER stress condition.
We next investigated the effect of exogenous FGF21 on tunicamycin-induced ER stress and hepatic lipid accumulation using liver-specific inducible Fgf21-transgenic mice. As expected, inducible Fgf21-transgenic mice had increased serum FGF21 levels and elevated hepatic Fgf21 gene expression when fed chow diet containing doxycycline (Fig. 3f, ESM  Fig. 4) . Importantly, these mice showed attenuated expression of UPR genes and decreased hepatic lipid accumulation after tunicamycin administration (Fig. 3g, h) . Together, these findings suggest that FGF21 expression is an adaptive response to ER stress to alleviate excessive liver injury and lipid accumulation. Obesity-mediated FGF21 induction alleviates lipid-induced ER stress, liver injury and metabolic deterioration Since ER stress occurs in the liver of obese mice [16] , we investigated the pathophysiological role of FGF21 in obesity-induced hepatic ER stress using Fgf21 −/− ob/ob mice. Consistent with previous reports [15, 16] , ob/ob mice exhibited increased hepatic Fgf21 expression and serum FGF21 levels compared with lean mice, together with upregulation of UPR genes and aggravated liver injury (Fig. 4a-c) . Importantly, we found that both male and female Fgf21 −/− ob/ob mice displayed increased serum AST and ALT levels compared with their respective control Fgf21 +/+ ob/ob mice, although differences in male mice were marginal (Fig. 4d, e) . In parallel, the expression of UPR genes was upregulated in the liver of female Fgf21 −/ − ob/ob mice compared with female controls (Fig. 4f) . These results suggest that obesity-mediated FGF21 induction serves as a protective mechanism to ameliorate obesity-induced ER stress and liver injury.
Given the role of ER stress in obesity-related metabolic diseases [12] , we next studied the role of FGF21 on obesitymediated metabolic derangement. Notably, both male and female Fgf21 −/− ob/ob mice displayed increased random-fed or fasting glucose levels and worsened glucose tolerance/ insulin resistance compared with their respective control Fgf21 +/+ ob/ob mice without changes in body weight ( Fig. 4g-j, ESM Fig. 5a-c) , although the differences in fasting glucose level in female mice were marginal. However, we did not observe any difference in metabolic profile between nonobese Fgf21 +/+ and Fgf21 −/− mice of either sex (ESM Fig. 6 ), suggesting that FGF21 deletion exacerbates metabolic variables only in the metabolically stressed condition. Despite deteriorated glucose tolerance and insulin resistance, serum insulin level, beta cell mass, beta cell apoptosis/proliferation and glucose-stimulated insulin secretion from islets were not different between Fgf21 −/− ob/ob and Fgf21 +/+ ob/ob mice (Fig. 4k-m, ESM Fig. 5d-f) , suggesting that beta cell dysfunction is not involved in metabolic deterioration of Fgf21 −/− ob/ob mice. As ER stress contributes to the increased gluconeogenesis in obesity and diabetes [19] , we conducted a PTT in Fgf21 −/− ob/ob mice. As expected, both male and female Fgf21 −/− ob/ob mice exhibited impaired pyruvate tolerance compared with Fgf21 +/+ ob/ob mice, accompanied by elevated expression of gluconeogenesis-related genes. However, differences in the PTTs of male mice were marginal (Fig. 4n-p) , implying that deteriorated glucose tolerance is probably due to increased hepatic glucose production. Nonetheless, hepatic lipid content and serum levels of metabolites, such as TG, cholesterol and NEFA, were not different between the two groups in both sexes (ESM Fig. 7a-d) . Together, these data suggest that obesitymediated FGF21 induction plays a protective role in obesityinduced ER stress and metabolic deterioration.
Discussion
Recent studies showed that FGF21 expression is increased in the liver of patients with and mouse models of obesity and NAFLD [13] [14] [15] . However, the molecular mechanism of FGF21 induction and its pathophysiological function in these conditions is unclear. Here, we demonstrated that a PERKeIF2α-ATF4 pathway is critical for ER stress-induced FGF21 expression in vitro and in vivo. Additionally, we showed a protective role of FGF21 in chemical-or obesity-induced hepatic ER stress. It has been reported that FGF21 is induced by various stresses, including glucose starvation, cold and autophagy deficiency, which may play an important role in adaptation to these stresses [3, 20, 21] . Additionally, a recent paper has reported that FGF21 levels are increased in hepatocytes and in mouse liver after treatment with an ER stressor [22] . However, the physiological or pathological significance of ER stressmediated FGF21 induction is unknown. Furthermore, molecular mechanisms of in vitro FGF21 induction by ER stress are unclear, although the effects of ATF4 overexpression on FGF21 mRNA expression and FGF21 promoter activity have been evaluated [22, 23] . Here, we demonstrated the importance of a PERK-eIF2α-ATF4 pathway in ER stress-induced Fgf21 expression in vivo and in vitro, and the physiological role of endogenous FGF21 induction caused by ER stress. In addition to ATF4, CHOP, the downstream target of ATF4, has been shown to be partially involved in ER stress-induced Fgf21 expression in primary hepatocytes [23] . However, we did not observe differences in Fgf21 expression between Chop +/+ and Chop −/− MEFs under ER stress conditions (ESM Fig. 8 ). During the course of the revision of our paper, the IRE1α-XBP1 pathway has been reported to mediate ER stress-induced FGF21 expression [24] , which is in contrast to our findings showing no significant role of IRE1α and XBP1 in FGF21 induction by ER stress. There is no clear explanation regarding these discrepancies, but they might be attributed to the differences in cell lines (hepatocytes vs MEFs) or experimental procedures. Fgf21 −/− mice exhibited an aggravated ER stress response and hepatic cell death compared with Fgf21 +/+ mice after tunicamycin administration, while inducible Fgf21-transgenic mice had an attenuated ER stress response, indicating that FGF21 plays a protective role against ER stress. However, we did not further address the mechanisms by which FGF21 alleviates ER stress or ER stress-induced liver injury in the present study. Several possible mechanisms may be proposed. First, downstream target proteins of FGF21 may participate in FGF21-mediated attenuation of ER stress. It has been reported that FGF21 activates the AMP-activated protein kinase (AMPK)-Sirtuin1 (SIRT1) pathway [25] , and AMPK or SIRT1 has a protective role against ER stress [26, 27] . We, therefore, hypothesise that AMPK or SIRT1 may mediate the effects of FGF21 on ER stress or hepatic injury due to ER stress. Another possibility is that reduced ER stress is a result of FGF21-induced suppression of lipid accumulation, since excessive lipid overloading can cause ER stress in the liver [28] . Given the protective role of FGF21 against oxidative stress in cardiac damage [29] , reduced oxidative stress may be a mechanism by which FGF21 alleviates ER stress-induced hepatic injury. Intriguingly, FGF21 has been reported to exert metabolic effects via its actions in other target organs such as brain and adipose tissue [30] [31] [32] . In particular, increased adiponectin levels derived from adipose tissue contribute to the metabolic improvement elicited by FGF21 [31, 32] . However, we did not observe changes of circulating adiponectin levels or adipose tissue Adipoq mRNA level in tunicamycintreated mice (ESM Fig. 9a, b) . In addition, serum adiponectin level in Fgf21 −/− mice was not different compared with Fgf21 +/+ mice after tunicamycin administration (ESM Fig. 9c) . Thus, we could exclude the contribution of adiponectin in the adaptive effect of FGF21 in response to ER stress. However, we still cannot eliminate the possibility that other changes in non-hepatic tissues contribute to the amelioration of hepatic ER stress by FGF21. Further studies will be necessary to elucidate the mechanisms underlying the protective role of FGF21 against ER stress.
As ER stress contributes to obesity-associated metabolic disease [16] and FGF21 expression is increased in patients with and mouse models of obesity [13] [14] [15] , we studied the pathophysiological function of FGF21 in ER stress and metabolic alterations caused by obesity using ob mice. While the metabolic effects of FGF21 deletion on diet-induced obesity models were variable [33, 34] , FGF21 deletion exacerbated hepatic ER stress and worsened glucose tolerance/insulin resistance in ob mice. However, alterations of these metabolic variables were not associated with beta cell failure. Our findings are inconsistent with previous reports showing beneficial effects of FGF21 on beta cell function and impairment of FGF21 signalling in islets of obese mice [35, 36] . This discrepancy is probably due to differences between exogenous FGF21 administration vs endogenous FGF21. Although the role of FGF21 in the regulation of gluconeogenesis is controversial [37] , we observed elevated gluconeogenesis in Fgf21 −/− ob/ob mice, which is consistent with previous reports showing suppressive effects of FGF21 on gluconeogenesis in obese conditions [5] . Together, our results suggest that endogenous FGF21 is important in alleviating ER stress and metabolic deterioration due to obesity.
In conclusion, our results indicate that FGF21 is induced in response to ER stress through the eIF2α-ATF4 axis, which serves as a compensatory mechanism to attenuate ER stressinduced liver injury and hepatic lipid accumulation. We also showed that FGF21 induction plays a protective role in obesity-related ER stress and metabolic deterioration. Thus, our findings provide new insights into the role of FGF21 in ER stress response and suggest an innovative therapeutic strategy for the treatment of ER stress-associated diseases such as NAFLD, obesity and diabetes.
